ReShape Lifesciences (RSLS, Financial) has entered an exclusive agreement with Motion Informatics, a company based in Haifa, Israel, to bring their cutting-edge neuromuscular rehabilitation devices to the United States market. This strategic collaboration focuses on the importation and distribution of these advanced medical devices, aiming to enhance rehabilitation options available within the U.S.
The centerpiece of this distribution agreement is the Stimel-03, a state-of-the-art product designed to aid neuromuscular recovery. The Stimel-03 was recently presented to industry professionals at the American Occupational Therapy Association 2025 Annual Conference and Expo, held from April 3 to 5 in Philadelphia, Pennsylvania. This showcase allowed for a comprehensive introduction of the device’s capabilities to occupational therapy specialists and stakeholders from across the nation.
This partnership reflects ReShape Lifesciences' commitment to expanding its product offerings and enhancing patient care solutions in the rehabilitation sector. The introduction of Motion Informatics' device aligns with ReShape’s strategy to leverage innovative technologies to address patient needs effectively.
